ArticleDiscover oncology2025

Ethyl β-carboline-3-carboxylate targets PRDX5/c-Jun axis for novel therapeutic strategy against cervical cancer.

Wan-Qiu Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.